New pain drug kindolor tosylate tested in healthy volunteers – trial halted early

NCT ID NCT06243835

Terminated Symptom relief Sponsor: Lohocla Research Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tested the safety and how the body processes Kindolor Tosylate, a potential new drug for chronic pain. It involved 16 healthy adults who received either the drug or a placebo. The study was terminated, so full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Kindolor Tosylate
What this could lead to: If successful, this could lead to a new pain medication for chronic pain conditions.
What could go wrong: This was an early Phase 1 trial in healthy volunteers, not patients, and it was terminated, so results are limited. The drug may not work or may have safety issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC PAIN

Contacts and locations

Locations

The Altman Clinical and Translational Research Institute

La Jolla, California, 92037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.